Primit Parikh - Dec 9, 2022 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
President and COO
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Stock symbol
TGAN
Transactions as of
Dec 9, 2022
Transactions value $
$0
Form type
4
Date filed
12/13/2022, 03:11 PM
Previous filing
Dec 1, 2022
Next filing
Jan 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TGAN Stock Option (right to buy) Award $0 +4.66K $0.00 4.66K Dec 9, 2022 Common Stock 4.66K $4.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-twelfth (1/12) of the shares subject to the option will vest in equal monthly installments, subject to the Reporting Person's continued service as of each such vesting date.